U.S. Momentum Factor Vanguard ETF (VFMO)

$177.52 -0.87 (-0.49%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 43,016
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund invests primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by investing in stocks with strong recent performance as determined by the advisor. The portfolio will include a diverse mix of companies representing many different market sectors and industry groups. Under normal circumstances, at least 80% of the fund's assets will be invested in securities issued by U.S. companies.

Phone: 6106696295
StocktwitsNews
StocktwitsNews Dec. 19 at 11:39 PM
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? $CYTK $VFMO $IWMW https://stocktwits.com/news/equity/markets/cytokinetics-wins-first-fda-approval-for-heart-disease-drug/cLe0aHTREtE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 19 at 2:23 PM
Lyft Draws Investor Attention After Wedbush Downgrades Stock Amid Autonomous Vehicle Risks $LYFT $UBER $WRD $VFMO https://stocktwits.com/news/equity/markets/lyft-draws-investor-attention-after-wedbush-downgrades-stock-amid-autonomous-vehicle-risks/cLeiUGhREsX
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 18 at 4:31 PM
Why Is CorMedix Stock Rising Today? $CRMD $VFMO https://stocktwits.com/news/equity/markets/why-is-cormedix-stock-rising-today/cLegM9dRErE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 17 at 10:20 PM
Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit $INSM $JGRO $VFMO https://stocktwits.com/news/equity/markets/insmed-stock-plunges-after-hours-as-sinus-drug-fails-mid-stage-trial/cLeOviDREAR
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 6:39 PM
JPMorgan Investment Banking Chief Plans Exit After 45 Years As Bank Ramps Up AI And Braces For $105B Costs: Report $JPM $VFMF $VFMO https://stocktwits.com/news/equity/markets/jpmorgan-investment-banking-chief-plans-exit-after-45-years-as-bank-ramps-up-ai-braces-for-105-billion-costs-report/cLe4OJPREor
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 3:11 PM
Palantir CIO Jim Siders To Depart After 12 Years To Head Thrive Capital’s New IT Services Business $PLTR $JGRO $VFMO https://stocktwits.com/news/equity/markets/palantir-cio-jim-siders-to-depart-after-12-years-to-head-thrive-capitals-new-it-services-business/cLe4EpiREoL
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 1:27 PM
ServiceNow Stock Is Down 5% Today — What’s Weighing On The Shares? $NOW $JGRO $VFMO https://stocktwits.com/news/equity/markets/servicenow-stock-is-down-5-percent-today-whats-weighing-on-the-shares/cLe42UmREoE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 11 at 9:46 PM
Broadcom Stock Jumps After Hours As Strong Q4 And Surging AI Chip Demand Drive Upbeat Outlook $AVGO $JGRO $VFMO https://stocktwits.com/news/equity/markets/broadcom-stock-jumps-after-hours-as-strong-q4-and-surging-ai-chip-demand-drive-upbeat-outlook/cLIxFFhREFd
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 11 at 6:22 PM
Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder $RYTM $VFMO $IWMW https://stocktwits.com/news/equity/markets/rhythm-pharmaceuticals-stock-rises-after-positive-study-data-for-setmelanotide-in-treating-genetic-disorder/cLIxj7cREFG
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 8 at 11:50 PM
Toll Brothers Stock Slides After-Hours On Q4 Miss And Softer Delivery Forecast $TOL $VFMF $VFMO https://stocktwits.com/news/equity/markets/toll-brothers-stock-slides-after-hours-on-q4-miss-and-softer-delivery-forecast/cLIp3SUREm6
0 · Reply
Latest News on VFMO
VFMO: An Useful Complement To The Russell 3000

Oct 14, 2025, 1:26 AM EDT - 2 months ago

VFMO: An Useful Complement To The Russell 3000

VFMO: Outperforming Other Momentum Strategies After The April Decline

Oct 11, 2025, 10:50 PM EDT - 2 months ago

VFMO: Outperforming Other Momentum Strategies After The April Decline

VFMO: Sticking With The Vanguard Momentum Strategy Amid Sector Rotation

Mar 28, 2025, 7:30 AM EDT - 9 months ago

VFMO: Sticking With The Vanguard Momentum Strategy Amid Sector Rotation

VFMO: Diversification A Negative For Vanguard's Momentum ETF

Jan 14, 2025, 3:39 AM EST - 1 year ago

VFMO: Diversification A Negative For Vanguard's Momentum ETF

VFMO: Strong Diversification, Solid Returns With This Momentum ETF

Oct 25, 2024, 11:19 PM EDT - 1 year ago

VFMO: Strong Diversification, Solid Returns With This Momentum ETF

VFMO: A Diversified Momentum ETF At Modest Valuation

Jul 18, 2024, 9:51 AM EDT - 1 year ago

VFMO: A Diversified Momentum ETF At Modest Valuation

VFMO: Inexpensive ETF Outperforming The S&P 500 And Peer Funds

Apr 30, 2024, 11:01 PM EDT - 1 year ago

VFMO: Inexpensive ETF Outperforming The S&P 500 And Peer Funds

Vanguard Has 17 Small And Mid-Cap ETFs. Which Are Best Right Now?

Mar 8, 2024, 2:55 AM EST - 1 year ago

Vanguard Has 17 Small And Mid-Cap ETFs. Which Are Best Right Now?

IVOG IVOO IVOV VBK VBR VFMF VFQY

You'd Be Surprised Which Four Vanguard ETFs Have Consistently Beaten Their Category Averages

Feb 18, 2024, 1:14 AM EST - 2 years ago

You'd Be Surprised Which Four Vanguard ETFs Have Consistently Beaten Their Category Averages

VFMF VFMV VFQY VFVA VO VOE VOO

VFMO: Assessing Momentum As A Strategy Versus SPY Near All-Time Highs

Feb 15, 2024, 4:48 AM EST - 2 years ago

VFMO: Assessing Momentum As A Strategy Versus SPY Near All-Time Highs

VFMO: Only One Tool In The Toolbox

Jun 14, 2023, 5:20 AM EDT - 2 years ago

VFMO: Only One Tool In The Toolbox

VFMO Vs. MTUM: Little Followed Momentum ETF Beating Better Known One

Jan 19, 2023, 9:30 AM EST - 3 years ago

VFMO Vs. MTUM: Little Followed Momentum ETF Beating Better Known One

MTUM

Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading

Apr 4, 2022, 9:16 AM EDT - 4 years ago

Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading

FFTY

QMOM ETF Ranked Best Among US Momentum Smart Beta ETFs

Aug 3, 2021, 12:29 PM EDT - 4 years ago

QMOM ETF Ranked Best Among US Momentum Smart Beta ETFs

QMOM

Why Vanguard Should Retire The U.S. Momentum Factor ETF

Feb 17, 2020, 9:18 AM EST - 6 years ago

Why Vanguard Should Retire The U.S. Momentum Factor ETF

StocktwitsNews
StocktwitsNews Dec. 19 at 11:39 PM
Cytokinetics Wins First FDA Approval For Heart Disease Drug — Why Is Wall Street Still Cautious? $CYTK $VFMO $IWMW https://stocktwits.com/news/equity/markets/cytokinetics-wins-first-fda-approval-for-heart-disease-drug/cLe0aHTREtE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 19 at 2:23 PM
Lyft Draws Investor Attention After Wedbush Downgrades Stock Amid Autonomous Vehicle Risks $LYFT $UBER $WRD $VFMO https://stocktwits.com/news/equity/markets/lyft-draws-investor-attention-after-wedbush-downgrades-stock-amid-autonomous-vehicle-risks/cLeiUGhREsX
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 18 at 4:31 PM
Why Is CorMedix Stock Rising Today? $CRMD $VFMO https://stocktwits.com/news/equity/markets/why-is-cormedix-stock-rising-today/cLegM9dRErE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 17 at 10:20 PM
Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit $INSM $JGRO $VFMO https://stocktwits.com/news/equity/markets/insmed-stock-plunges-after-hours-as-sinus-drug-fails-mid-stage-trial/cLeOviDREAR
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 6:39 PM
JPMorgan Investment Banking Chief Plans Exit After 45 Years As Bank Ramps Up AI And Braces For $105B Costs: Report $JPM $VFMF $VFMO https://stocktwits.com/news/equity/markets/jpmorgan-investment-banking-chief-plans-exit-after-45-years-as-bank-ramps-up-ai-braces-for-105-billion-costs-report/cLe4OJPREor
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 3:11 PM
Palantir CIO Jim Siders To Depart After 12 Years To Head Thrive Capital’s New IT Services Business $PLTR $JGRO $VFMO https://stocktwits.com/news/equity/markets/palantir-cio-jim-siders-to-depart-after-12-years-to-head-thrive-capitals-new-it-services-business/cLe4EpiREoL
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 15 at 1:27 PM
ServiceNow Stock Is Down 5% Today — What’s Weighing On The Shares? $NOW $JGRO $VFMO https://stocktwits.com/news/equity/markets/servicenow-stock-is-down-5-percent-today-whats-weighing-on-the-shares/cLe42UmREoE
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 11 at 9:46 PM
Broadcom Stock Jumps After Hours As Strong Q4 And Surging AI Chip Demand Drive Upbeat Outlook $AVGO $JGRO $VFMO https://stocktwits.com/news/equity/markets/broadcom-stock-jumps-after-hours-as-strong-q4-and-surging-ai-chip-demand-drive-upbeat-outlook/cLIxFFhREFd
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 11 at 6:22 PM
Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder $RYTM $VFMO $IWMW https://stocktwits.com/news/equity/markets/rhythm-pharmaceuticals-stock-rises-after-positive-study-data-for-setmelanotide-in-treating-genetic-disorder/cLIxj7cREFG
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 8 at 11:50 PM
Toll Brothers Stock Slides After-Hours On Q4 Miss And Softer Delivery Forecast $TOL $VFMF $VFMO https://stocktwits.com/news/equity/markets/toll-brothers-stock-slides-after-hours-on-q4-miss-and-softer-delivery-forecast/cLIp3SUREm6
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 3 at 4:58 PM
Micron To Stop Selling Crucial Consumer Products As It Heightens Focus On Larger Customers $MU $VFMO $RSPT https://stocktwits.com/news/equity/markets/micron-to-stop-selling-crucial-consumer-products/cLIXwsjRE1A
0 · Reply
StocktwitsNews
StocktwitsNews Dec. 3 at 9:20 AM
American Eagle's Gen Z Playbook Is Working — Sydney Sweeney And Travis Kelce Might Only Be The Opening Act $AEO $VFMF $VFMO $IWMW https://stocktwits.com/news/equity/markets/american-eagle-gen-z-playbook-is-working-with-sydney-sweeney-and-travis-kelce/cLIXmZpREKM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:55 AM
$VENU $VERI $VFF $VFMO $VGT
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 28 at 12:43 PM
Abercrombie & Fitch Catches Retail Attention After Barclays Raises Price Target On Hollister Momentum $ANF $VFMO $IWMW https://stocktwits.com/news/equity/markets/abercrombie-fitch-catches-retail-attention-after-barclays-raises-price-target-on-hollister-momentum/cL5abTzRELe
1 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 1:25 PM
Why ANF Stock Is Soaring Before The Bell Today? $ANF $VFMO $IWMW https://stocktwits.com/news/equity/markets/why-anf-stock-is-soaring-before-the-bell-today/cL520AyREXv
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 24 at 1:52 PM
$VENU $VERI $VFF $VFMO $VGT
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 20 at 4:08 PM
Micron Stock Draws Investor Attention Following A Price Target Boost From UBS $MU $VFMO $SPXV $AVUS https://stocktwits.com/news/equity/markets/micron-stock-draws-investor-attention-following-a-price-target-boost-from-ubs/cLPANWCREaK
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 19 at 1:43 PM
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial $AGIO $VFMO $IWMW https://stocktwits.com/news/equity/markets/agio-stock-cracks-after-sickle-cell-disease-drug-delivers-mixed-results-in-late-stage-trial/cLPoaX1REB0
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 18 at 3:20 PM
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results $OLMA $RHHBY $VFMO https://stocktwits.com/news/equity/markets/olma-stock-doubles-after-roche-cancer-drug-trial-yields-positive-results/cLPVEMLRE7q
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 14 at 5:51 PM
Why Did Scholar Rock Soar 26% Today? $SRRK $VFMO $IWMW $NVO https://stocktwits.com/news/equity/markets/scholar-rock-eyes-reapplication-for-approval-of-muscle-atrophy-therapy-in-2026/cLPQ17HRE4q
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 12 at 2:59 PM
Uber COO Says Robotaxi Tech Is Largely Ready But Hardware Costs Are Still Too High $UBER $JGRO $VFMO https://stocktwits.com/news/equity/markets/uber-coo-says-robotaxi-tech-is-largely-ready-but-hardware-costs-are-still-too-high/cLPICXdREd7
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 12 at 1:33 PM
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance $CRMD $VFMO $IWMW https://stocktwits.com/news/equity/markets/cormedix-stock-soars-pre-market-after-earnings-beat-higher-full-year-guidance/cLPIUcNREdG
0 · Reply